Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
1h
Ozempic Link to Rare Vision Loss Risk Confirmed in Large Trial
Novo Nordisk A/S’s blockbuster shot Ozempic was linked to an increased risk of a rare form of vision loss in a study that ...
2h
on MSN
Ozempic Works on Kidney Disease, Regulator Says. Why Novo Nordisk Stock Is Falling.
Novo Nordisk’s blockbuster drug Ozempic got another star added to its label Thursday, in an encouraging sign for the ...
FiercePharma
4h
Novo Nordisk’s chief scientific officer looks to the future of GLP-1s
GLP-1 agonists have taken the pharma world by storm, and Novo Nordisk has been at the forefront of it all thanks to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Singer Wallen sentenced
Reveals cancer diagnosis
Two US states sue Glock
WV lawmaker arrested
Ice storm warning issued
Trump backs dockworkers
On NJ drone sightings
Today in history: 2000
Fake electors case revived
Sues alcohol distributor
Announces he’s cancer-free
Jan. 6 riot watchdog report
Stanley recalls 2.6M mugs
Introduces seating lottery
$1M to inaugural fund?
Combs faces 3 new suits
YouTube TV raises rates
Steps up driver ID checks
SpaceX eyes TX city creation
$14.25M penalty upheld
Ex-informant to plead guilty
RU targets UKR energy grid
Louisville police reform deal
To restructure its business
Adams meets with Homan
SEC reopens probe
FAA administrator to resign
Laments loss of privacy
US citizen found in Syria
Plane crashes into cars
Feedback